1/2
Sensorion and EVEON collaborate on the development of an injection system for delivering gene therapy treatments to the inner ear
Montpellier, January 31, 2023 – Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company dedicated to the development of innovative therapies to restore, treat and prevent hearing loss, and EVEON, designer and manufacturer of medical devices for the preparation and drug delivery, announce that they are collaborating on the design and development of an injection system to deliver Sensorion’s gene therapy products into the inner ear, including the drug candidate OTOF-GT.